1 03, 2021 A breakthrough for the targeted therapy of RET+ tumours with new selective inhibitors Diatech Pharmacogenetics2021-03-01T15:25:16+01:00 Mehr erfahren
21 12, 2020 Hope of a cure for cholangiocarcinoma coming from FGFR inhibitors Diatech Pharmacogenetics2020-12-22T11:57:21+01:00 Mehr erfahren
28 09, 2020 Alpelisib and PIK3CA mutations: a new molecular targeted therapy for breast cancer is approved Diatech Pharmacogenetics2020-09-28T18:43:55+02:00 Mehr erfahren
29 06, 2020 New European recommendations on DPD testing prior to anticancer therapy with fluoropyrimidines Diatech Pharmacogenetics2020-06-29T17:33:09+02:00 Mehr erfahren
16 04, 2020 A new therapeutic opportunity treatment of NSCLC: the BRAF V600 mutation Diatech Pharmacogenetics2020-04-16T17:00:25+02:00 Mehr erfahren
